Beijing Succeeder Technology Inc. (SHA:688338)

Market Cap	2.48B
Revenue (ttm)	300.23M
Net Income (ttm)	108.66M
Shares Out	103.97M
EPS (ttm)	1.03
PE Ratio	23.19
Forward PE	20.08
Dividend	0.26 (1.09%)
Ex-Dividend Date	Jun 6, 2024

Volume	837,412
Average Volume	668,584
Open	23.92
Previous Close	23.91
Day's Range	23.92 - 24.44
52-Week Range	19.91 - 31.20
Beta	0.45
RSI	47.44
Earnings Date	Aug 22, 2025

About SHA:688338

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers automatic detection instruments, including coagulation, hemorheology, hematocrit, and platelet aggregation, as well as supporting reagents and consumables. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding diseases. Beijing Succeeder Technology...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 296
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688338

Financial Performance

In 2024, SHA:688338's revenue was 305.87 million, an increase of 11.03% compared to the previous year's 275.49 million. Earnings were 113.00 million, a decrease of -3.35%.